title: [Priority for atypical antipsychotic drugs? Current studies clarify the issues].
authors.affiliation: m.dose@bkh-taufkirchen.de
authors.forename: Matthias
authors.initials: M
authors.lastname: Dose
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D010352:Patient Dropouts / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents